I. Lavi
- Urology top 5%
- Urinary Bladder and Prostate Research 2
-
- Antibiotic Use and Resistance 2
- Hematology top 10%
- Rheumatology top 10%
- Spondyloarthritis Studies and Treatments 3
- Rheumatoid Arthritis Research and Therapies 3
- Molecular Medicine top 10%
-
- Urinary Tract Infections Management 3
-
- Pediatric Urology and Nephrology Studies 2
-
- Psoriasis: Treatment and Pathogenesis 2
-
- Growth Hormone and Insulin-like Growth Factors 2
- Co-authors
- Raanan RazNaiel BisharatHussam OmariReuven MaderGad RennertNaomi GronichYoram KennesBibiana Chazan
- Journals
- Annals of the Rheumatic Diseases (3 papers)Journal of the European Academy of Dermatology and Venereology (2 papers)Infection (2 papers)
- Partner nations
- IsraelUnited StatesCzechia
In The Last Decade
I. Lavi
22 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 107
- Urology 139
- Applied Microbiology and Biotechnology 38
- Hematology 138
- Rheumatology 142
- Molecular Medicine 45
Countries citing papers authored by I. Lavi
This map shows the geographic impact of I. Lavi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Lavi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Lavi more than expected).
Fields of papers citing papers by I. Lavi
This network shows the impact of papers produced by I. Lavi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Lavi. The network helps show where I. Lavi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside I. Lavi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2018 | 1 | |
| 4 | 2018 | 1 | |
| 5 | 2017 | 23 | |
| 6 | 2011 | 21 | |
| 7 | 2011 | 83 | |
| 8 | 2010 | 23 | |
| 9 | 2009 | 31 | |
| 10 | 2008 | 13 | |
| 11 | 2008 | 74 | |
| 12 | 2005 | 30 | |
| 13 | 2003 | 57 | |
| 14 | 2002 | 11 | |
| 15 | 2002 | 170 | |
| 16 | 2001 | 45 | |
| 17 | 2001 | 330 | |
| 18 | 2001 | 40 | |
| 19 | 2000 | 12 | |
| 20 | Demographic characteristics of patients with community-acquired bacteriuria and susceptibility of urinary pathogens to antimicrobials in northern Israel. | 2000 | 23 |
About I. Lavi
I. Lavi is a scholar working on Applied Microbiology and Biotechnology, Rheumatology, Urology, Internal Medicine and Dermatology, having authored 23 papers that have together received 1.1k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (3 papers), Urinary Tract Infections Management (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Antibiotic Use and Resistance (2 papers), Pediatric Urology and Nephrology Studies (2 papers), Psoriasis: Treatment and Pathogenesis (2 papers), Growth Hormone and Insulin-like Growth Factors (2 papers) and Urinary Bladder and Prostate Research (2 papers). The work is most often cited by research in Urology (139 citations), Applied Microbiology and Biotechnology (38 citations), Hematology (138 citations), Rheumatology (142 citations) and Molecular Medicine (45 citations). I. Lavi has collaborated with scholars based in Israel, United States and Czechia. Frequent co-authors include Raanan Raz, Naiel Bisharat, Hussam Omari, Reuven Mader, Gad Rennert, Naomi Gronich, Yoram Kennes, Bibiana Chazan, Raul Colodner and M. Dan. Their work appears in journals such as Annals of the Rheumatic Diseases, Journal of the European Academy of Dermatology and Venereology, Infection, Dermatology and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.